Physician profile
Michael Flores
NPI 1053586305
$2,206.45
in general payments reported to CMS, 2019-2025
14 companies · $539 in 2025
The $539 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $321 · 2022: $148 · 2023: $490 · 2024: $707 · 2025: $539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,737.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $562.64 | 2022-2025 | Dupixent, Evkeeza, Praluent |
| Glaxosmithkline, LLC. | $514.79 | 2023-2025 | Trelegy Ellipta, Arexvy |
| Janssen Pharmaceuticals, INC | $208.91 | 2021-2023 | Xarelto |
| Otsuka America Pharmaceutical, INC. | $145.07 | 2023-2024 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $143.57 | 2025 | Farxiga |
| Nestle Healthcare Nutrition INC. | $124.74 | 2023 | |
| Aimmune Therapeutics, INC. | $124.74 | 2024 | |
| Madrigal Pharmaceuticals | $122.90 | 2024 | Rezdiffra |
| Horizon Therapeutics Plc | $112.12 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.82 | 2025 | Relistor, Xifaxan |
| Ge Healthcare | $27.99 | 2025 | |
| Smith+Nephew, INC. | $23.80 | 2024 | Collagenase Santyl |
| Exact Sciences Corporation | $21.25 | 2024 | Cologuard Collection Kit |
| Allergan, INC. | $18.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Flores listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.